Tokyo, Japan

Tomohisa Toyama

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Asahi Kasei Pharma Corporation, Vernalis (R&D) Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomohisa Toyama. Retrieved from https://idiyas.com/inventor/tomohisa-toyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0



Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomohisa Toyama: Innovator in Medicinal Chemistry

Introduction

Tomohisa Toyama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with therapeutic potential. Although he currently holds no granted patents, his work continues to influence the industry.

Latest Patent Applications

One of Tomohisa Toyama's recent patent applications is for a macrocyclic compound. This compound is represented by the general formula (1) or a salt thereof, which exhibits superior IRAK-4 inhibitory activity. It is useful as an active ingredient in medicaments for the prophylactic and therapeutic treatment of diseases related to IRAK-4 inhibition.

Conclusion

Tomohisa Toyama's innovative work in medicinal chemistry highlights his commitment to advancing healthcare solutions. His contributions, particularly in the area of IRAK-4 inhibition, showcase the potential for future developments in this vital field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…